Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Marimed (MRMD) over the last 15 years, with Q3 2025 value amounting to $205.6 million.

  • Marimed's Liabilities and Shareholders Equity fell 332.99% to $205.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $825.0 million, marking a year-over-year increase of 76.84%. This contributed to the annual value of $207.0 million for FY2024, which is 554.04% up from last year.
  • As of Q3 2025, Marimed's Liabilities and Shareholders Equity stood at $205.6 million, which was down 332.99% from $204.4 million recorded in Q2 2025.
  • Marimed's Liabilities and Shareholders Equity's 5-year high stood at $212.7 million during Q3 2024, with a 5-year trough of $90.0 million in Q1 2021.
  • In the last 5 years, Marimed's Liabilities and Shareholders Equity had a median value of $189.4 million in 2023 and averaged $169.1 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 6319.68% in 2021, then tumbled by 332.99% in 2025.
  • Over the past 5 years, Marimed's Liabilities and Shareholders Equity (Quarter) stood at $123.2 million in 2021, then increased by 23.54% to $152.2 million in 2022, then rose by 28.86% to $196.1 million in 2023, then grew by 5.54% to $207.0 million in 2024, then decreased by 0.67% to $205.6 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $205.6 million for Q3 2025, versus $204.4 million for Q2 2025 and $208.0 million for Q1 2025.